Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Hyperlipidemias × Olanzapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 3 Nausea 3 Hematologic Neoplasms 2 Sedentary Behavior 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Insulin Resistance 1 Hyperlipidemias 1 Hyperglycemia 1 Gynecologic Cancer 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms 1

Interventions

ziprasidone 1 Olanzapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00910988 2018-07-18

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Washington University School of Medicine

Phase NA Completed

46 enrolled 38 charts

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡